Plants are attractive expression systems for the economic production of recombinant proteins. Among the different plant-based systems, plant seed is the leading platform and holds several advantages such as high protein yields and stable storage of target proteins. Significant advances in using seeds as bioreactors have occurred in the past decade, which include the first commercialized plant-d...

The production of hydrogen via microbial biotechnology is an active field of research. Given its ease of manipulation, the best-studied bacterium Escherichia coli has become a workhorse for enhanced hydrogen production through metabolic engineering, heterologous gene expression, adaptive evolution, and protein engineering. Herein, the utility of E. coli strains to produce hydrogen, via native h...

Polyhydroxyalkanoates (PHA) are biodegradable, thermoplastic polyesters produced from renewable carbon sources by a number of bacteria. However, their application is limited by high production costs. One of the strategies aimed to reduce their costs is the development of recombinant strains able to utilize different carbon sources. Many bacteria are naturally capable of accumulating biopolyeste...

Increasing interest in recombinant protein technologies for human and animal health applications has spotlighted microalgae as a platform with the potential to meet a large impending demand. Here we describe an algae protein expression system and compare the advantages and disadvantages to other platforms currently operating on a commercial level. High-value recombinant proteins that have been ...

Resveratrol production in Saccharomyces cerevisiae was compared to that in Escherichia coli. In both systems, 4-coumarate:coenzyme A ligase from tobacco and stilbene synthase from grapes were expressed. When p-coumaric acid was used as the precursor, resveratrol accumulations in the culture medium were observed to be comparable in E. coli (16 mg/liter) and yeast (6 mg/liter).